14 results
8-K
EX-1.1
RLAY
Relay Therapeutics Inc
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
a Material Adverse Effect. Neither the Company nor its subsidiaries have received any notice of cancellation or termination with respect to any collective … bargaining agreement to which it is a party.
(cc)Certain Environmental Matters. (i) The Company and its subsidiaries (x) are in compliance with all
8-K
EX-1.1
RLAY
Relay Therapeutics Inc
14 Oct 21
Relay Therapeutics Announces Proposed Public Offering of Common Stock
4:15pm
received any notice of cancellation or termination with respect to any collective bargaining agreement to which it is a party.
(cc)Certain Environmental
S-3ASR
EX-1.2
RLAY
Relay Therapeutics Inc
12 Aug 21
Automatic shelf registration
5:11pm
Adverse Effect. Neither the Company nor its subsidiary has received any notice of cancellation or termination with respect to any collective bargaining agreement
8-K
EX-2.1
noehdqne52efric
16 Apr 21
Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI
6:38am
10-K
tk3usuqo17
25 Mar 21
Annual report
4:31pm
424B4
eu7h 81df1u
16 Jul 20
Prospectus supplement with pricing info
4:34pm
S-1/A
EX-1.1
sp4nfg
9 Jul 20
IPO registration (amended)
7:17am
S-1/A
e87us
9 Jul 20
IPO registration (amended)
7:17am
S-1
9woxp44h9wskp05plle
24 Jun 20
IPO registration
5:03pm
DRS
ksymqks9nalzer
22 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next